San Antonio’s innovative nanotherapy company working to improve the safety and efficacy of chemotherapy drugs.

BD, a leading global medical technology company that manufactures and sells medical devices, instrument systems and reagents, is dedicated to improving people’s health throughout the world. BD is focused on improving drug therapy, enhancing the quality and speed of diagnosing infectious diseases, and advancing research and discovery of new drugs and vaccines. Founded in 1897, BD employs over 27,000 people worldwide and serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public.

Biomedical Development Corporation is commercializing a portfolio of pharmaceuticals that decrease bacterial bioburden in the mouth, reduce chronic inflammation, and subsequently improve systemic health. Biomedical Development Corporation has two drugs in Phase 2 clinical trials.

BME’s business initiatives as a medical device manufacturer and research service provider have allowed it to increase the medical community’s knowledge in osteoporosis, bone healing, and bone replacement materials. BME's strategy is focused on minimally invasive orthopaedic instrumentation and implants that elicit a biologic response.

BioNumerik Pharmaceuticals’ vision is to discover and develop innovative new cancer treatments by the integration of medicine, pharmaceutical sciences, physics-based molecular simulation and high-performance information technology.

Bone Bank Allografts is located in San Antonio, Texas and is the distributor of the SteriGraft™ line of high quality bone and soft tissue allografts to medical professionals. The company has been in existence for over 13 years and has helped doctors and their patients with over one hundred thousand successful transplantations.

Celldyne BioPharma, LLC’s mission is to develop novel therapies for metabolic diseases with application to worldwide markets, including wasting diseases, obesity, and obesity-related diseases such as type 2 diabetes. The company adopts, where possible, a "virtual" structure, minimizing infrastructure and overhead costs while maximizing access to world-class expertise. Outsourcing activities are closely controlled by management, which has the benefit of substantial skills and experience in the clinical development of drugs, the management of research and a high-level of decision-making experience in the international pharmaceutical industry. We offer consulting in development, manufacturing and commercialization of products in the pharmaceutical, biologic, diagnostic, and nutraceutical industries.

CMI, a woman-owned, small disadvantaged business, is a biotechnology and software engineering company with core competencies in biological research, bioinformatics, modeling, and simulation. CMI's commercial product is an Electronic Health Record called SevocityTM.

A contract development and manufacturing organization (CDMO) offering full service sourcing solutions for the world’s leading pharmaceutical, biotechnology and healthcare companies.

At ENTrigue Surgical, Inc., we are harnessing breakthroughs in biotechnology and instrument design to develop novel, yet sensible solutions for the ENT operating room and office. Our initial focus is on enhancing surgical access for increased functionality and precision. In addition, we are also developing a unique class of proven bioabsorbable and biologic implants designed to simplify surgical procedures and improve healing.

Electrochemical Oxygen Concepts, Inc. (EO_² Concepts™) is an innovative wound care company based in San Antonio, TX. It's first product, the TransCu O_²™ device, is a unique, non-invasive, electrochemical tissue oxygenation system intended for use with lower-cost moist wound dressings for the treatment of diabetic foot ulcers, venous leg ulcers, pressure ulcers and other skin wounds through the continuous diffusion of oxygen. The goal of our therapy is to continuously supply pure oxygen to an oxygen-compromised wound to aid in wound healing while maintaining a moist wound healing environment, maintaining patient mobility and significantly reducing costs.

Evestra seeks to improve the health and wellness of women around the world through innovative technologies and commercially viable products focused primarily on fertility control, gynecological disorders and oncology.

A development stage oncology company focused on therapeutics which deliver a potent, unique and patented drug directly to tumors.

Genzyme Corporation is developing and commercializing novel treatments for cancer through internal research and active collaborations.  Marketed products are Campath® and Clolar®.

KCI is a global medical technology company that designs and manufactures a wide range of proprietary products that can improve clinical outcomes and can help reduce the overall cost of patient care.

At Medtronic, Innovating for life means we’re committed to finding more ways to help more people around the world. Constantly pushing the limits of medical technology. Driven by our deep understanding of the human body and our collaboration with physicians, we're transforming technology to treat patients across the entire care continuum. Our innovations help physicians diagnose diseases earlier, treat patients with the least amount of disruption possible, and help alleviate symptoms throughout the patient's life.

For more than sixty years, privately held Mission Pharmacal has been dedicated to identifying unmet health needs and developing innovative products to meet them.

Ovna Medical's mission is to improve human health by offering technologies that provide real-time detection and diagnostics of certain cancers and heart disease. The core technology utilizes a fiber optic spectroscopy device for real-time diagnostics and monitoring. Our unique devices will save costs, improve medical care, and help save lives through earlier detection.

Paragonix Technologies is commercializing single-use and highly portable Organ Preservation and Transport Devices for transplant organs. Our devices are based on scientific principles that improve the quality of lives for patients receiving transplants, will increase the number of available organs for transplantation, and will reduce deaths of patients on waiting lists. This technology overcomes known logistical challenges that compromise current procurement and transportation of transplant organs.

An emerging leader innovating aptamer-based, hand-held diagnostic assay development that eliminates culture enrichment for real-time, rapid testing for food/water safety, homeland security.

QualTex Laboratories performs testing services for clients that collect, prepare, and distribute FDA regulated blood components/biological products for human therapies. Tests performed are used to qualify blood/plasma donors and support global public safety.

Rochal Industries is a privately owned bioscience company focusing on the development of new polymeric materials for wound and burn care treatment.  Rochal licenses its intellectual property to companies capable of commercializing the resulting products.

Seno Medical Instruments Inc. is focused on the early detection of cancer through the use of its patented opto-acoustic imaging technology.

StemBioSys manufactures and develops novel, proprietary stem cell technologies to meet the promise of regenerative medicine in a surging global market. Housed in San Antonio, StemBioSys is led by an experienced management and scientific team.

The leading developer, manufacturer, and marketer of advanced intraosseous technology which offers the potential to establish new standaards of clinical excellence in the safe, rapid performance of medical procedres using the intraosseous space. The Wall Street Journal named Vidacare's EZ-IO Vascular Access System its sole Technology Innovation of the Year Gold Award recipient in 2008. Vidacare products are marketed in over 50 countries worldwide.

ViroXis is a biopharmaceutical company focused on developing and commercializing innovative, proprietary, botanical pharmaceuticals derived from Sandalwood oil.

Voxelogix Corporation provides the most comprehensive suite of digitally integrated restorative services and products for full arch dental implant patients.

The Texas Technology Development Center (T3DC) is a not for profit economic development subsidiary of the Texas Research and Technology Foundation.  T3DC manages a seed investment fund and a business accelerator.